Allison M Kehlmann

4PUBLICATIONS
85CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

|Jun 10, 2024
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants.

Sienna M Durbin, Debra M Lundquist, Andrea Pelletier

|Nov 02, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.

Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin

Pageof 1

Frequent Collaborators

4 joint publications

Dejan Juric

3 joint publications

Nicholas J Chevalier

3 joint publications

Janice S Kim

3 joint publications

Andreas Varkaris